Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/1999
06/02/1999EP0918545A2 Tumour therapy
06/02/1999EP0918539A1 Vaccine for b-cell malignancies
06/02/1999EP0918534A1 Peptidyl prodrugs and methods of making and using the same
06/02/1999EP0918532A1 A novel method of detecting and treating cancer
06/02/1999EP0918522A1 Antagonists of gonadotropin releasing hormone
06/02/1999EP0918514A1 Triaryl methane compounds for sickle cell disease
06/02/1999EP0845036B1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/02/1999EP0740581A4 Particulate material
06/02/1999EP0675729B1 ACTIVATION OF p53 PROTEIN
06/02/1999CN1218512A Recombinant adenoviral vectors for human tumour gene therapy
06/02/1999CN1218478A Cyclic adhesion inhibitors
06/02/1999CN1218475A Taxane derivatives preparation thereof and formulation containing them
06/02/1999CN1218474A Camptothecin-skeleton compounds isolated from mappia foetida and use thereof as syntones for medicaments as well as therapeutical agents
06/02/1999CN1218456A Irreversible inhibitors of tyrosine kinases
06/02/1999CN1218411A Method of killing target cells in harvested cell populations
06/02/1999CN1218409A Stimulation of host defence mechanisms against viral challenges
06/02/1999CN1218408A Method of treatment
06/02/1999CN1218406A HLA-A2.1 binding peptides and their uses
06/02/1999CN1218403A Formulation for use in prevention of pathogen induced diseases including HIV and HSV
06/02/1999CN1218400A Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
06/02/1999CN1218047A Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
06/02/1999CN1217931A Medicines for various cancers
06/02/1999CN1043531C Pyrimidine derivatives and a process for production thereof
06/02/1999CN1043528C Method for preparation of taxol using an oxazinone
06/01/1999US5908933 Certain 4H- 1!benzopyrano 3,4-b!pyridine derivatives and their corresponding 6,7-b! and 7,8-b! ring isomers
06/01/1999US5908919 Drug delivery
06/01/1999US5908851 Derivatives of succinamide and their use as metalloproteinase inhibitor
06/01/1999US5908845 Polyether nucleic acids
06/01/1999US5908843 Thrombosis, antiinflammatory agent, arteriosclerosis, antitumor agents
06/01/1999US5908835 Anti-tumor compositions containing taxane derivatives
06/01/1999US5908827 Protein from urine named component B
06/01/1999US5908778 Mage-10 encoding cDNA, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof
06/01/1999US5908626 Genetic engineering
05/1999
05/27/1999WO1999025877A1 Reagents and methods useful for detecting diseases of the breast
05/27/1999WO1999025860A1 Vector for tissue-specific replication and gene expression
05/27/1999WO1999025843A2 Human checkpoint kinase, hcds1, compositions and methods
05/27/1999WO1999025834A1 Dna19355 polypeptide, a tumor necrosis factor homolog
05/27/1999WO1999025832A1 Toso
05/27/1999WO1999025830A1 Transcriptionally regulated g protein-coupled receptor
05/27/1999WO1999025729A1 Compounds with antitumor activity
05/27/1999WO1999025718A1 5H-PYRANO[2,3-d:6,5-d']DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL AND IMMUNO-MODULATING ACTIVITY
05/27/1999WO1999025705A1 Recovery of taxanes from plant material
05/27/1999WO1999025701A1 NOVEL HETEROCYCLICALLY SUBSTITUTED α-HYDROXYCARBOXLIC ACID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS
05/27/1999WO1999025699A1 Salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydial, antiviral and immuno-modulating activity
05/27/1999WO1999025695A1 5-arylpyrazole compounds
05/27/1999WO1999025693A1 Metalloproteinase inhibitors
05/27/1999WO1999025687A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/27/1999WO1999025379A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999WO1999025378A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999WO1999025377A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
05/27/1999WO1999025376A1 Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens
05/27/1999WO1999025375A2 DIRECT CYTOTOXIC ACTIVITY BY ANTI-hCG MONOCLONAL ANTIBODIES
05/27/1999WO1999025367A2 Treatment of hematologic disorders
05/27/1999WO1999025341A1 Use of histamine for elevating blood histamine levels
05/27/1999WO1999025320A1 Targeted liposome gene delivery
05/27/1999WO1999025195A1 Purging of stem cell products
05/27/1999WO1999014346A3 SENSE mRNA THERAPY
05/27/1999WO1999013908A9 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent
05/27/1999WO1999012964A3 Kay - a novel immune system protein
05/27/1999WO1999012961A8 Estrogen receptor
05/27/1999WO1999010480A3 New tissue-specific calpaines, their production and their use
05/27/1999WO1999010371A3 Cyclopeptide derivatives as adhesion inhibitors
05/27/1999CA2739604A1 Targeted liposome gene delivery
05/27/1999CA2310563A1 Vector for tissue-specific replication and gene expression
05/27/1999CA2310410A1 Salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydial, antiviral and immuno-modulating activity
05/27/1999CA2310332A1 Recovery of taxanes from plant material
05/27/1999CA2310328A1 Purging of stem cell products
05/27/1999CA2310269A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999CA2310255A1 Use of histamine for elevating blood histamine levels
05/27/1999CA2309990A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999CA2309919A1 Treatment of hematologic disorders
05/27/1999CA2309758A1 Reagents and methods useful for detecting diseases of the breast
05/27/1999CA2309343A1 Toso
05/27/1999CA2309339A1 Transcriptionally regulated g protein-coupled receptor
05/27/1999CA2308746A1 Novel heterocyclically substituted .alpha.-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor_antagonists
05/27/1999CA2308365A1 Dna19355 polypeptide, a tumor necrosis factor homolog
05/27/1999CA2306492A1 Human checkpoint kinase, hcds1, compositions and methods
05/27/1999CA2306460A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/26/1999EP0918059A1 Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
05/26/1999EP0917572A2 Secreted proteins and polynucleotides encoding them
05/26/1999EP0917570A2 Mhc binding peptide oligomers and methods of use
05/26/1999EP0917569A2 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
05/26/1999EP0917539A1 Anticoagulant peptide fragments derived from apolipoprotein b-100
05/26/1999EP0917538A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications
05/26/1999EP0917464A1 Use of amines to produce drugs for preventing tumour cell proliferation
05/26/1999EP0917458A1 Lyophilized thioxanthenone antimumor agents
05/26/1999EP0817769B1 Borneol esters, process for their preparation and their pharmaceutical use
05/26/1999EP0678034B1 Inducing cytotoxic t lymphocyte responses
05/26/1999EP0616641B1 Humanized b-b10, an anti-il2 receptor antibody
05/26/1999EP0611372B1 Photosensitizers
05/26/1999EP0453560B1 Localization and characterization of the wilms' tumor gene
05/26/1999CN1217750A Monoclonal antibody to CEA, Conjugates comprising said antibody, and their therapeutic use in ADEPT system
05/26/1999CN1217719A Novel benzofuranone derivative and process for producing same
05/26/1999CN1217714A Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF)
05/26/1999CN1217662A Water soluble paclitaxel prodrugs
05/26/1999CN1217332A Metal protease inhibitor, preparation method therefor and medicinal composition containing same
05/26/1999CN1217209A Anti-cancer medicine
05/26/1999CN1217185A Anti-tumor noval use of cinnamamide
05/26/1999CA2254434A1 Droloxifene pharmaceutical compositions
05/25/1999US5907042 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
1 ... 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 ... 2211